Here we report that adults with type 2 diabetes have significantly up-regulated surface expression of CD40 and CD80 with a lag of 2 and 3 days and significantly elevated CD86, HLA-DR, and CD23 expression at a lag of 4 days on circulating monocytes. The gene discussed is CD86; the disease is type 2 diabetes mellitus.